
Joshua Brody/LinkedIn
Apr 16, 2025, 09:11
Joshua Brody: Mobilizing dendritic cells to teach T cells to recognize and kill tumors
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared a post on LinkedIn:
“Elegant genetic cancer immunotherapy from yizhoudong lab Tisch Cancer Sinai Immunol mobilizing dendritic cells to teach T cells to recognize and kill tumors!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 11, 2025, 18:14
May 11, 2025, 18:05
May 11, 2025, 17:07
May 11, 2025, 16:57
May 11, 2025, 16:49